These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16529810)

  • 41. Principles of transmucosal delivery of therapeutic agents.
    Blanchette J; Kavimandan N; Peppas NA
    Biomed Pharmacother; 2004 Apr; 58(3):142-51. PubMed ID: 15082336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, characterization and in vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels.
    Tuesca AD; Reiff C; Joseph JI; Lowman AM
    Pharm Res; 2009 Mar; 26(3):727-39. PubMed ID: 19145407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response of intestinal cells and macrophages to an orally administered cellulose-PEG based polymer as a potential treatment for intractable edemas.
    Esposito A; Sannino A; Cozzolino A; Quintiliano SN; Lamberti M; Ambrosio L; Nicolais L
    Biomaterials; 2005 Jul; 26(19):4101-10. PubMed ID: 15664637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydrogels: are they keeping their heads above water?
    Williams D
    Med Device Technol; 1995 Sep; 6(7):8-11. PubMed ID: 10155398
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan.
    Lee E; Lee J; Jon S
    Bioconjug Chem; 2010 Oct; 21(10):1720-3. PubMed ID: 20849099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PEGylated insulin loaded complexation hydrogels for protected oral delivery.
    Coolich MK; Lanier OL; Cisneros E; Peppas NA
    J Control Release; 2023 Dec; 364():216-226. PubMed ID: 37890591
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nanoparticle strategies for the oral delivery of insulin.
    Damgé C; Reis CP; Maincent P
    Expert Opin Drug Deliv; 2008 Jan; 5(1):45-68. PubMed ID: 18095928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tyrphostin-8 enhances transferrin receptor-mediated transcytosis in Caco-2- cells and inreases hypoglycemic effect of orally administered insulin-transferrin conjugate in diabetic rats.
    Xia CQ; Shen WC
    Pharm Res; 2001 Feb; 18(2):191-5. PubMed ID: 11405290
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poly(hydroxyethyl methacrylate)-based co-polymeric hydrogels for transdermal delivery of salbutamol sulphate.
    Suhag GS; Bhatnagar A; Singh H
    J Biomater Sci Polym Ed; 2008; 19(9):1189-200. PubMed ID: 18727860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bifunctional monolithic affinity hydrogels for dual-protein delivery.
    Lin CC; Metters AT
    Biomacromolecules; 2008 Mar; 9(3):789-95. PubMed ID: 18257528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transcellular delivery of an insulin-transferrin conjugate in enterocyte-like Caco-2 cells.
    Shah D; Shen WC
    J Pharm Sci; 1996 Dec; 85(12):1306-11. PubMed ID: 8961144
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.
    Morishita M; Goto T; Nakamura K; Lowman AM; Takayama K; Peppas NA
    J Control Release; 2006 Feb; 110(3):587-94. PubMed ID: 16325951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Supramolecular hydrogels based on self-assembly between PEO-PPO-PEO triblock copolymers and alpha-cyclodextrin.
    Ni X; Cheng A; Li J
    J Biomed Mater Res A; 2009 Mar; 88(4):1031-6. PubMed ID: 18404710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The complexation between novel comb shaped amphiphilic polyallylamine and insulin: towards oral insulin delivery.
    Thompson CJ; Tetley L; Uchegbu IF; Cheng WP
    Int J Pharm; 2009 Jul; 376(1-2):46-55. PubMed ID: 19375489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent developments in superporous hydrogels.
    Omidian H; Park K; Rocca JG
    J Pharm Pharmacol; 2007 Mar; 59(3):317-27. PubMed ID: 17331335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biodegradable poly(ethylene glycol)-peptide hydrogels with well-defined structure and properties for cell delivery.
    Liu SQ; Ee PL; Ke CY; Hedrick JL; Yang YY
    Biomaterials; 2009 Mar; 30(8):1453-61. PubMed ID: 19097642
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
    Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
    Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-binding hydrogels of hyaluronic acid functionalized with beta-cyclodextrin.
    Zawko SA; Truong Q; Schmidt CE
    J Biomed Mater Res A; 2008 Dec; 87(4):1044-52. PubMed ID: 18257063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complexation hydrogels for intestinal delivery of interferon beta and calcitonin.
    Kamei N; Morishita M; Chiba H; Kavimandan NJ; Peppas NA; Takayama K
    J Control Release; 2009 Mar; 134(2):98-102. PubMed ID: 19095021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.